Metraipolis › archive › dc_f5506da0f1c8

The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database — Europe PMC PMID:41293236

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41293236
DOI
10.3389/fphar.2025.1702875
License (as archived)
solo-consultazione
Archived
2026-11-08T16:38:07.576Z
SHA-256 of the archived text
7c3c66ffb718d0ffa7b2476501377ee7fcc4577e3ebd20e5a568f69d0d96aa67
Stable URL of this page
https://metraipolis.com/documento/dc_f5506da0f1c8

How to cite

The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database — Europe PMC PMID:41293236 — Europe PMC (en), https://europepmc.org/article/MED/41293236 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5506da0f1c8 (Metraipolis archive dc_f5506da0f1c8, sha256 7c3c66ffb718d0ffa7b2476501377ee7fcc4577e3ebd20e5a568f69d0d96aa67)
BibTeX
@misc{dcf5506da0f1c8,
  title = {The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database — Europe PMC PMID:41293236},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41293236},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5506da0f1c8; sha256 7c3c66ffb718d0ffa7b2476501377ee7fcc4577e3ebd20e5a568f69d0d96aa67},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293236. Agents can read the archived copy with the MCP tool read_document.